Business Context and Reporting Period
Company: Lucid Diagnostics Inc. (LUCD)
Filing Type: Form 8-K (Current Report)
Date of Report: March 26, 2026
Reporting Period: Fiscal Year Ended December 31, 2025
Context: The filing announces the issuance of a press release containing financial results for the fiscal year ended December 31, 2025, and provides a business update. The company is registered on The Nasdaq Stock Market LLC and is classified as an emerging growth company.
Key Financial Metrics
The provided text is a cover page and index for the Form 8-K. It references a press release (Exhibit 99.1) containing the actual financial data but does not include the specific figures within this document.
- Revenue: Not provided in this text.
- Profit/Loss: Not provided in this text.
- Cash Flow: Not provided in this text.
- Margins: Not provided in this text.
- Debt and Liquidity: Not provided in this text.
Material Changes
The filing text does not provide specific numerical comparisons or material changes versus the prior comparable period. It only confirms that results for the fiscal year ended December 31, 2025, have been announced.
Guidance, Outlook, and Risks
Management Commentary: The company issued a business update alongside the financial results, but the specific content of this update is not detailed in the filing text.
Guidance and Outlook: No specific forward-looking guidance or outlook figures are present in this document.
Risks and Contingencies: No specific risks or contingencies are detailed in this text. The filing notes that the information furnished under Items 2.02 and 7.01 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) attached to the full filing to obtain actual revenue, profit, and cash flow figures for the fiscal year ended December 31, 2025.
- Verify the specific details of the "business update" mentioned in Item 2.02, as the summary text does not elaborate on operational milestones or strategic shifts.
- Confirm the company's status as an emerging growth company and any associated implications for financial reporting standards.
- Check the Regulation FD Disclosure (Item 7.01) to ensure no additional non-public information was released simultaneously.